摘要:
A pharmaceutical composition for use as a retinal pigment epithelial cell growth stimulating agent comprising an interferon and a pharmaceutically acceptable carrier is disclosed. The composition is useful as a therapeutic agent for oculopathies, such as pigmentary retinal degeneration, central chorioretinopathy, and macular dystrophy.
摘要:
The invention provides methods for treating retinal edema, particularly cystoid macular edema, employing interferon (IFN)-.alpha., IFN-.beta., or IFN-.gamma.. The IFN may be administered locally, orally, or parenterally.